Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focused on oncology and obesity therapies, announced CEO Yuval Cohen will present corporate updates and meet investors at two major healthcare conferences in New York: the RBC Capital Markets Global Healthcare Conference on May 19, 2026, and the Jefferies Global Healthcare Conference on June 4, 2026. These presentations provide Corbus an opportunity to showcase its pipeline, including CRB-701 for cancer and CRB-913 for obesity, to potential investors and partners. The events are webcast, allowing broader access to the company's strategic outlook and progress. This engagement highlights Corbus's efforts to advance its clinical programs and attract investment ahead of key regulatory and trial milestones.
Investors who sold Activision Blizzard stock between January 18, 2022, and October 13, 2023, have until June 30, 2026, to apply to be lead plaintiffs in a class action lawsuit. The suit alleges that Activision Blizzard and its board made false and mi...
Defiance ETFs has introduced the Defiance Daily Target 2X Short SpaceX ETF (SPCQ), designed to provide twice the inverse daily performance of SpaceX stock (SPCX). This ETF targets active traders seeking short-term bearish exposure to SpaceX, a leadin...
Defiance ETFs introduced the Defiance Daily Target 2X Short SpaceX ETF (SPCQ), designed to provide investors with double inverse exposure to SpaceX's daily stock price movements. This ETF aims to deliver -200% of SpaceX's daily returns, allowing inve...
Defiance ETFs introduced the Defiance Daily Target 2X Short SpaceX ETF (SPCQ), designed for active traders seeking double inverse daily exposure to SpaceX stock. The ETF aims to deliver -200% of SpaceX's daily price movements, allowing investors to b...
Defiance ETFs has introduced the Defiance Daily Target 2X Short SpaceX ETF (SPCQ), designed for active traders seeking amplified daily inverse exposure to SpaceX stock. This ETF aims to deliver -200% of SpaceX's daily price movements, allowing invest...
